All In Biotech

Drug Trial Radar · NCT03167905

CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)

Comparison of the Role of Epidural Analgesia Versus Non-epidural Analgesia in Postnatal Depression and Persistent Pain Development: a Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 881 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

881

Actual

Start

Jun 15, 2017

Primary completion

Jul 19, 2021

Study completion Dec 31, 2027

Sponsor

Lead sponsor
KK Women's and Children's HospitalGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
May 30, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 21 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Postnatal depression affects about 10-15% of women after childbirth. Approximately 3-5% of women experience a moderate-to-severe depression that requires medical attention. This study aims to investigate the implication of pain relief choice in reducing the postnatal depression of women who deliver their babies.

Conditions

  • Depression, Postpartum
  • Analgesia, Obstetrical
  • Anesthesia, Obstetrical

Interventions

  • Epidural delivery systemDevice

    Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.

  • EntonoxDrug

    Entonox will be given upon request in non-epidural group.

  • MeperidineDrug

    Intramuscular pethidine (75mg/1.5ml) will be given upon request in non-epidural group.

  • UltivaDrug

    Intravenous patient controlled remifentanil (20-40mcg/ml) is only given when the patient rejects or cannot receive pethidine and entonox in non-epidural group..

  • FentanylDrug

    Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.

  • RopivacaineDrug

    Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of major postnatal depression in both groupsTime frame: 6-10 weeks after delivery
  2. The incidence of (clinically significant, probable) postnatal depression in both groupsTime frame: 6-10 weeks after delivery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • KK Women's and Children's Hospital

    Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.